Volume | 18,589 |
|
|||||
News | - | ||||||
Day High | 0.5481 | Low High |
|||||
Day Low | 0.507 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Exicure Inc | XCUR | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.519 | 0.507 | 0.5481 | 0.515 | 0.5403 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
153 | 18,589 | $ 0.523061 | $ 9,723 | - | 0.3647 - 1.50 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:00:00 | 112 | $ 0.515 | USD |
Exicure Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
4.41M | 8.65M | - | 28.83M | -2.58M | -0.30 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Exicure News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical XCUR Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.6159 | 0.6295 | 0.507 | 0.5705282 | 20,745 | -0.1009 | -16.38% |
1 Month | 0.6326 | 0.728 | 0.50 | 0.6114228 | 44,965 | -0.1176 | -18.59% |
3 Months | 0.5676 | 0.793 | 0.50 | 0.6520268 | 230,043 | -0.0526 | -9.27% |
6 Months | 0.625 | 0.86 | 0.3647 | 0.5996518 | 515,348 | -0.11 | -17.60% |
1 Year | 0.99 | 1.50 | 0.3647 | 0.6223907 | 270,735 | -0.475 | -47.98% |
3 Years | 1.80 | 3.24 | 0.0846 | 0.3705364 | 2,627,711 | -1.29 | -71.39% |
5 Years | 2.20 | 3.84 | 0.0846 | 0.5167031 | 1,782,859 | -1.69 | -76.59% |
Exicure Description
Exicure Inc is a clinical-stage biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology. |